Sterling Heights, MI, United States of America

Adam David DeJans, Jr


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adam David DeJans, Jr.: Innovator in Multi-Modal Journey Optimization

Introduction

Adam David DeJans, Jr. is an accomplished inventor based in Sterling Heights, MI (US). He has made significant contributions to the field of transportation technology, particularly in optimizing multi-modal journeys. His innovative approach aims to enhance the efficiency of transit systems.

Latest Patents

Adam holds a patent for "Transit-routing expediter systems and methods for multi-modal journey optimization." This patent outlines a method that includes determining journey parameters such as origin and destination locations, as well as the time of departure. The method also involves determining various paths based on these parameters, which may include route-based options, non-route-based options, or walking options. Additionally, it calculates arrival times for these paths and identifies optimal solutions through iterative analysis.

Career Highlights

Adam is currently employed at Ford Global Technologies, LLC, where he applies his expertise in transportation systems. His work focuses on developing innovative solutions that improve the efficiency of transit routing and journey optimization.

Collaborations

Adam has collaborated with notable colleagues, including Ali Mirtar and Mohammad Abouali, to further advance the field of transportation technology. Their combined efforts contribute to the development of cutting-edge solutions in multi-modal journey optimization.

Conclusion

Adam David DeJans, Jr. is a pioneering inventor whose work in transit-routing systems is shaping the future of transportation. His innovative patent and contributions to Ford Global Technologies, LLC highlight his commitment to enhancing journey optimization.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…